NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a premier artificial intelligence (AI) company transforming clinical trials with AI-powered ...

Recent studies have suggested that sugar substitutes might not be the free lunch they're advertised as. We asked experts what ...

A new sci-fi thriller from enterprise technology veteran and Ai2 board chair Bill Hilf imagines an AI built on living biology ...

Extreme heat events have been demonstrated to increase emergency department (ED) visits, hospitalizations, and mortality, but evidence of their impacts on the associated costs and on outpatient use is ...

Multiple research fronts saw major advances on April 24, 2026, with AI models driving new capabilities in protein interaction prediction, automated protein design, and earthquake engineering ...

Chronic intranasal oxytocin alters neural connectivity in ASD but fails to significantly improve core behavioral outcomes, according to AAN data.

As clinical development activity expands for psychedelic drug programs and other emerging CNS therapeutics, NetraMark believes that advanced, explainable analytics will become inc ...

Blood-pressure reduction is the only proven treatment to prevent stroke. Whether a single pill that combines three ...

Chronic kidney disease (CKD) has long remained at the margins of the evidence base for the cardiovascular benefits of blood-pressure lowering. The absolute risk of cardiovascular events in people with ...

Scintil is known for its work in DWDM laser sources for AI. Using its SHIP™ (Scintil Heterogeneous Integrated Photonics) ...

Psychiatric disorders affect millions worldwide, but their diagnosis still relies on clinical observation instead of standard biological tests.

New research on the gut-vagina axis links intestinal dysbiosis to bacterial vaginosis, candidiasis, and genitourinary syndrome of menopause — with implications for probiotics and prevention.